Participated · Series A · Jul 2026

Flourish Health delivers intensive in-home mental health care for children and young adults through psychiatrist-led Care Pods composed of a child and adolescent psychiatrist, a licensed therapist, a patient guide, and a family guide. The company built a proprietary technology platform that integrates patient touchpoints, EMR and prescribing capabilities, workflow automation, team collaboration, and AI to support engagement and coordination while clinicians make clinical decisions. Flourish specializes in three clinical populations: children with externalizing behaviors, young people with multiple suicide attempts or suicide-related hospitalizations, and patients with complex needs and family situations often turned away by other clinics. Studies run with multiple major health plans report large reductions in hospitalization (70–96%), residential treatment (69–90%), and sustained decreases in higher levels of care post-discharge (80–95%). Flourish commits to beginning care within one week of referral, reports 92% month-over-month retention during its 12-month programs, and says those programs cost less than one month of inpatient treatment.

Participated · Series B · Feb 2025

Camber offers a proprietary platform that reduces administrative burdens on clinics and families by automating and simplifying insurance and Medicaid claims processing. Its data‑driven models streamline workflows and improve accuracy, averaging a 95% first‑pass acceptance rate. Over the past two years Camber has grown to serve 90,000 patients across 40 states and has managed $2 billion in claims. The platform has focused on reimbursement needs for behavioral health clinics treating pediatric patients with autism, Down syndrome, and depression. With the new funding, Camber plans to expand into home health, long‑term care, and substance use disorder services and to reach new patient populations and clinics across the United States. By addressing fraud, inefficiencies, and administrative complexity, Camber aims to improve provider cash flow and patient access to care.

Participated · Series D · Feb 2025

Abridge builds AI scribe technology that automates medical notes and integrates with Epic Systems. The company says its technology is used by over 150 of the largest U.S. health systems. In Q1 Abridge reported $117 million in contracted annual recurring revenue (a metric that includes signed recurring contracts, including customers not yet onboarded). It is expanding into converting medical notes from patient appointments into AI-powered medical codes, a move that positions it against startups like CodaMetrix and features from Epic. Abridge is widely considered a leader in the AI-powered medical scribe market due to early entry and Epic integration. The company was founded by cardiologist Shiv Rao and is seven years old. Abridge provides an enterprise-grade generative AI platform that transforms medical conversations into clinically useful and billable documentation at the point of care. The platform maps AI-generated summaries to source data using Linked Evidence to make outputs auditable and verifiable. It integrates deeply with EHRs, supports 28+ languages and 50+ specialties, and is used across outpatient, emergency department, and inpatient settings. Abridge says it has been deployed in more than 100 health systems, with enterprise implementations at Duke Health, Johns Hopkins, Mayo Clinic, UNC Health and others, representing tens of thousands of clinicians. The company recently introduced a Contextual Reasoning Engine to incorporate retrospective encounters, revenue-cycle rules, and clinician preferences to produce more comprehensive, billable notes and capture orders for EHRs. The Series D funding will support continued AI research and commercial growth to broaden applications and reduce clinician administrative burden. Abridge builds an AI-powered virtual medical scribe and clinical note-taking product that records patient encounters and generates editable visit notes. The company began with a free smartphone transcription app whose usage helped train its proprietary medical LLM on thousands of doctor–patient conversations. Its virtual scribe supports 14 foreign languages and has secured a right to be integrated inside Epic so notes can appear directly in the EHR for clinician verification. Large health systems are buying multi‑thousand-seat licenses, and Abridge has been announcing a new health system customer nearly every week since the start of 2024 (customers named include University of Chicago, Sutter, Yale, Lee Health, Christus and Emory). The company says its product materially reduces physicians’ administrative burden and has been described by customers as “life-changing” and “magical.” Abridge faces competition from incumbents and other AI scribe vendors, and observers note the open question of whether general foundation models could narrow its lead over time. Abridge builds generative AI for clinical documentation, transforming patient–clinician conversations into structured clinical notes in real time with deep EMR integrations. The platform uses Linked Evidence and auditable AI that maps AI-generated summaries to ground truth to help providers trust and verify outputs. Its stack orchestrates language identification, transcription, alignment, diarization, summarization, and verification models to produce and validate notes within seconds, reducing clinician latency from minutes to seconds. Abridge is collaborating with NVIDIA to leverage NVIDIA compute resources, foundation models, and deployment expertise to scale deployments across clinicians in the U.S. and eventually internationally. The company emphasizes research into clinically specialized foundation models, medical speech and language technology, and responsible AI. Abridge was founded in 2018 and is based in Pittsburgh, Pa. Abridge builds AI that captures and summarizes spoken patient–clinician conversations, converting them into structured clinical note drafts in real time. Its audio and ambient AI solutions integrate with EHR systems and allow patients to review notes, medication instructions, treatments, and follow-ups. The company highlights peer-reviewed R&D in medical conversation AI and user experience design. Abridge’s tools support both in-person and telemedicine appointments and aim to free clinicians from clerical work so they can focus on patients. The company says it has spent the last five years developing its technology. SCAN Group began offering Abridge’s service as a supplemental benefit in 2021.

Participated · Seed · Jun 2024

TestParty builds AI-powered tools that automate testing, remediation, training, and code monitoring to bring websites into compliance with accessibility standards such as the European Accessibility Act and the Americans with Disabilities Act. The product automatically rewrites source code so existing engineers can produce ADA-compliant code instead of hiring costly accessibility specialists. Founders Michael Bervell (CEO) and Jason Tan (CTO) launched the company in March 2023 after Tan's experience at Twitch highlighted widespread accessibility shortcomings. The team aims to replace manual consultant audits by scaling automation to meet rising regulatory pressure, including the EU's enforcement beginning in 2025 and expanding U.S. mandates. The article notes the compliance-management market tops well over $30 billion and positions TestParty as a way to make accessibility more affordable with social impact. TestParty announced a $4 million seed round to further its work on automated accessibility tooling.